HalisKaanAkturkMD
Endocrinology • Aurora, CODiabetes, Lipid Metabolism
Associate professor of medicine and pediatrics
Dr. Akturk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Barbara Davis Center for Diabetes
Aurora, CO 80045
Summary
- Dr. Halis Akturk is an endocrinologist in Aurora, CO and is affiliated with University of Colorado Hospital. He received his medical degree from Istanbul University Faculty of Medicine and has been in practice 10 years. He also speaks multiple languages, including Turkish and German. He is experienced in type i diabetes mellitus, tumor immunotherapy, insulin pump management, type ii diabetes, and continuous glucose monitoring.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2011 - 2014
Istanbul University FomClass of 2007
Certifications & Licensure
CO State Medical License 2016 - 2025
FL State Medical License 2014 - 2018
NE State Medical License Active through 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Young Internists of 2011 European Federation of Internal Medicine, 2011
Publications & Presentations
PubMed
- Long-term glycaemic improvement with the initiation of an automated insulin delivery system in insulin pump-naïve older adults with type 1 diabetes.Kagan E Karakus, Emma Mason, Halis K Akturk
Diabetes, Obesity & Metabolism. 2025-01-01 - A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes.Irl B Hirsch, Roy W Beck, Martin C Marak, Yogish Kudva, Halis K Akturk
Diabetes Care. 2024-12-06 - Improvement in Newly Defined Continuous Glucose Monitor Metrics, Extended Hypoglycemia, and Extended Hyperglycemia With Automated Insulin Delivery Initiation in Adults...Kagan E Karakus, Janet Snell-Bergeon, Emma Mason, Halis K Akturk
Journal of Diabetes Science and Technology. 2024-12-05
Journal Articles
- PD-1 Inhibitor Immune-Related Adverse Events in Patients with Preexisting Endocrine AutoimmunityHalis Kaan Akturk, Aaron W Michels, The Journal of Clinical Endocrinology and Metabolism
- The Cortisol Stress Response Induced by Surgery: A Systematic Review and Meta‐AnalysisHalis Kaan Akturk, Irina Bancos, Clinical Endocrinology
- Linagliptin for the treatment of Type 2 diabetesTella SH, Akturk HK, Rendell M, Diabetes Management, 2014
Authored Content
- Highlights in ADA 2022 for Diabetes Technologies and TherapeuticsJune 2022
- Highlights in ADA 2021 for Diabetes Technologies and TherapeuticsJuly 2021
Press Mentions
Pot Use Tied to Serious Diabetes ComplicationNovember 8th, 2018
Additional Positive Afrezza® Clinical Data from STAT Study to Be Presented at ADA 78th Scientific SessionsJune 25th, 2018
'Adrenal Support' Supplements May Contain Unsafe IngredientsApril 26th, 2018- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Member
Other Languages
- Turkish, German
External Links
- Akraba Evliligi( Consanguineous marriages and autosomal recessive disorders)http://www.akrabaevliligi.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
